Cargando…

Survival Prediction Using Transformer-Based Categorical Feature Representation in the Treatment of Diffuse Large B-Cell Lymphoma

Diffuse large B-cell lymphoma (DLBCL) is a common and aggressive subtype of lymphoma, and accurate survival prediction is crucial for treatment decisions. This study aims to develop a robust survival prediction strategy to integrate various risk factors effectively, including clinical risk factors a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pant, Sudarshan, Kang, Sae-Ryung, Lee, Minhee, Phuc, Pham-Sy, Yang, Hyung-Jeong, Yang, Deok-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137756/
https://www.ncbi.nlm.nih.gov/pubmed/37108006
http://dx.doi.org/10.3390/healthcare11081171
_version_ 1785032543582552064
author Pant, Sudarshan
Kang, Sae-Ryung
Lee, Minhee
Phuc, Pham-Sy
Yang, Hyung-Jeong
Yang, Deok-Hwan
author_facet Pant, Sudarshan
Kang, Sae-Ryung
Lee, Minhee
Phuc, Pham-Sy
Yang, Hyung-Jeong
Yang, Deok-Hwan
author_sort Pant, Sudarshan
collection PubMed
description Diffuse large B-cell lymphoma (DLBCL) is a common and aggressive subtype of lymphoma, and accurate survival prediction is crucial for treatment decisions. This study aims to develop a robust survival prediction strategy to integrate various risk factors effectively, including clinical risk factors and Deauville scores in positron-emission tomography/computed tomography at different treatment stages using a deep-learning-based approach. We conduct a multi-institutional study on 604 DLBCL patients’ clinical data and validate the model on 220 patients from an independent institution. We propose a survival prediction model using transformer architecture and a categorical-feature-embedding technique that can handle high-dimensional and categorical data. Comparison with deep-learning survival models such as DeepSurv, CoxTime, and CoxCC based on the concordance index (C-index) and the mean absolute error (MAE) demonstrates that the categorical features obtained using transformers improved the MAE and the C-index. The proposed model outperforms the best-performing existing method by approximately 185 days in terms of the MAE for survival time estimation on the testing set. Using the Deauville score obtained during treatment resulted in a 0.02 improvement in the C-index and a 53.71-day improvement in the MAE, highlighting its prognostic importance. Our deep-learning model could improve survival prediction accuracy and treatment personalization for DLBCL patients.
format Online
Article
Text
id pubmed-10137756
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101377562023-04-28 Survival Prediction Using Transformer-Based Categorical Feature Representation in the Treatment of Diffuse Large B-Cell Lymphoma Pant, Sudarshan Kang, Sae-Ryung Lee, Minhee Phuc, Pham-Sy Yang, Hyung-Jeong Yang, Deok-Hwan Healthcare (Basel) Article Diffuse large B-cell lymphoma (DLBCL) is a common and aggressive subtype of lymphoma, and accurate survival prediction is crucial for treatment decisions. This study aims to develop a robust survival prediction strategy to integrate various risk factors effectively, including clinical risk factors and Deauville scores in positron-emission tomography/computed tomography at different treatment stages using a deep-learning-based approach. We conduct a multi-institutional study on 604 DLBCL patients’ clinical data and validate the model on 220 patients from an independent institution. We propose a survival prediction model using transformer architecture and a categorical-feature-embedding technique that can handle high-dimensional and categorical data. Comparison with deep-learning survival models such as DeepSurv, CoxTime, and CoxCC based on the concordance index (C-index) and the mean absolute error (MAE) demonstrates that the categorical features obtained using transformers improved the MAE and the C-index. The proposed model outperforms the best-performing existing method by approximately 185 days in terms of the MAE for survival time estimation on the testing set. Using the Deauville score obtained during treatment resulted in a 0.02 improvement in the C-index and a 53.71-day improvement in the MAE, highlighting its prognostic importance. Our deep-learning model could improve survival prediction accuracy and treatment personalization for DLBCL patients. MDPI 2023-04-19 /pmc/articles/PMC10137756/ /pubmed/37108006 http://dx.doi.org/10.3390/healthcare11081171 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pant, Sudarshan
Kang, Sae-Ryung
Lee, Minhee
Phuc, Pham-Sy
Yang, Hyung-Jeong
Yang, Deok-Hwan
Survival Prediction Using Transformer-Based Categorical Feature Representation in the Treatment of Diffuse Large B-Cell Lymphoma
title Survival Prediction Using Transformer-Based Categorical Feature Representation in the Treatment of Diffuse Large B-Cell Lymphoma
title_full Survival Prediction Using Transformer-Based Categorical Feature Representation in the Treatment of Diffuse Large B-Cell Lymphoma
title_fullStr Survival Prediction Using Transformer-Based Categorical Feature Representation in the Treatment of Diffuse Large B-Cell Lymphoma
title_full_unstemmed Survival Prediction Using Transformer-Based Categorical Feature Representation in the Treatment of Diffuse Large B-Cell Lymphoma
title_short Survival Prediction Using Transformer-Based Categorical Feature Representation in the Treatment of Diffuse Large B-Cell Lymphoma
title_sort survival prediction using transformer-based categorical feature representation in the treatment of diffuse large b-cell lymphoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137756/
https://www.ncbi.nlm.nih.gov/pubmed/37108006
http://dx.doi.org/10.3390/healthcare11081171
work_keys_str_mv AT pantsudarshan survivalpredictionusingtransformerbasedcategoricalfeaturerepresentationinthetreatmentofdiffuselargebcelllymphoma
AT kangsaeryung survivalpredictionusingtransformerbasedcategoricalfeaturerepresentationinthetreatmentofdiffuselargebcelllymphoma
AT leeminhee survivalpredictionusingtransformerbasedcategoricalfeaturerepresentationinthetreatmentofdiffuselargebcelllymphoma
AT phucphamsy survivalpredictionusingtransformerbasedcategoricalfeaturerepresentationinthetreatmentofdiffuselargebcelllymphoma
AT yanghyungjeong survivalpredictionusingtransformerbasedcategoricalfeaturerepresentationinthetreatmentofdiffuselargebcelllymphoma
AT yangdeokhwan survivalpredictionusingtransformerbasedcategoricalfeaturerepresentationinthetreatmentofdiffuselargebcelllymphoma